MedPath

Efficacy of Self-hypnosis combined with Citalopram on the Stait- Trait Anxiety in patients with Generalized Anxiety Disorder and Quality of Life

Phase 2
Conditions
Generalized Anxiety Disorder.
Anxiety that is generalized and persistent but not restricted to, or even strongly predominating in, any particular environmental circumstances (i.e. it is
Registration Number
IRCT2015091023966N1
Lead Sponsor
Vice chancellor for research, Semnan University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Diagnosis of Generalized Anxiety Disorder (GAD) by psychiatrist; Without comorbid disorders; To have not severe physical illness
Exclusion criteria: Under treatment or other educational program ; The absence of more than two sessions

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Generalized Anxiety Disorder. Timepoint: Baseline-After intervention-Two months after intervention. Method of measurement: Spielberger's State-Trait Anxiety Inventory.;Quality of Life. Timepoint: Baseline- After the intervention-Two months after the intervention. Method of measurement: The World Health Organization Quality of Life Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath